Skip to search formSkip to main contentSkip to account menu

Methimazole

Known as: 2H-Imidazole-2-thione, 1,3-dihydro-1-methyl-, Methimazole [Chemical/Ingredient], Merkazolil 
A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Abstract Melanogenesis is a process to synthesize melanin, which is a primary responsible for the pigmentation of human skin, eye… 
Review
2015
Review
2015
IMPORTANCE Graves disease is the most common cause of persistent hyperthyroidism in adults. Approximately 3% of women and 0.5% of… 
Highly Cited
2010
Highly Cited
2010
BACKGROUND The antithyroid drugs propylthiouracil and methimazole were introduced for clinical use about 60 yr ago and are… 
Highly Cited
2007
Highly Cited
2007
CONTEXT Although methimazole (MMI) and propylthiouracil (PTU) have long been used to treat hyperthyroidism caused by Graves… 
Highly Cited
2003
Highly Cited
2003
RiassuntoLe malattie autoimmuni della tiroide sono caratterizzate dalla presenza di anticorpi diretti contro la tireoperossidasi… 
Review
1999
Review
1999
We report on a further case of congenital anomalies in a child exposed to methimazole during the first trimester of pregnancy… 
Review
1999
Review
1999
Atrial fibrillation is the most common, potent risk factor for ischemic stroke. Nonrheumatic atrial fibrillation, the predominant… 
Highly Cited
1998
Highly Cited
1998
BACKGROUND The chief clinical characteristics of Graves' disease are hyperthyroidism and ophthalmopathy. The relation between the… 
Highly Cited
1980
Highly Cited
1980
Renal membranes (crude microsomal fraction) which catalyze the thiol-dependent outer ring deiodination of LT4 with the formation…